SonoScape Medical Corp (SHE:300633) — Market Cap & Net Worth
Market Cap & Net Worth: SonoScape Medical Corp (300633)
SonoScape Medical Corp (SHE:300633) has a market capitalization of $1.28 Billion (CN¥8.76 Billion) as of August 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #7723 globally and #1701 in its home market, demonstrating a 7.83% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SonoScape Medical Corp's stock price CN¥20.24 by its total outstanding shares 432712405 (432.71 Million). See 300633 capital expenditure intensity to understand how much of operating cash flow is reinvested back into capital assets.
SonoScape Medical Corp Market Cap History: 2017 to 2026
SonoScape Medical Corp's market capitalization history from 2017 to 2026. Data shows growth from $1.72 Billion to $1.28 Billion (11.44% CAGR).
Index Memberships
SonoScape Medical Corp is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$1.18 Trillion | 0.11% | #92 of 100 |
Weight: SonoScape Medical Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
SonoScape Medical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SonoScape Medical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.72x
SonoScape Medical Corp's market cap is 0.72 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.48x
SonoScape Medical Corp's market cap is 8.48 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.72 Billion | $989.07 Million | $190.02 Million | 1.74x | 9.03x |
| 2018 | $1.71 Billion | $1.23 Billion | $252.62 Million | 1.40x | 6.78x |
| 2019 | $1.49 Billion | $1.25 Billion | $101.54 Million | 1.19x | 14.68x |
| 2020 | $1.61 Billion | $1.16 Billion | -$46.26 Million | 1.39x | N/A |
| 2021 | $1.99 Billion | $1.44 Billion | $247.24 Million | 1.38x | 8.06x |
| 2022 | $3.43 Billion | $1.76 Billion | $369.81 Million | 1.95x | 9.28x |
| 2023 | $2.97 Billion | $2.12 Billion | $454.44 Million | 1.40x | 6.54x |
| 2024 | $1.86 Billion | $2.01 Billion | $142.40 Million | 0.92x | 13.07x |
| 2025 | $1.67 Billion | $2.31 Billion | $197.28 Million | 0.72x | 8.48x |
Competitor Companies of 300633 by Market Capitalization
Companies near SonoScape Medical Corp in the global market cap rankings as of August 1, 2026.
Key companies related to SonoScape Medical Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
SonoScape Medical Corp Historical Marketcap From 2017 to 2026
Between 2017 and today, SonoScape Medical Corp's market cap moved from $1.72 Billion to $ 1.28 Billion, with a yearly change of 11.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.28 Billion | -23.39% |
| 2025 | CN¥1.67 Billion | -10.11% |
| 2024 | CN¥1.86 Billion | -37.34% |
| 2023 | CN¥2.97 Billion | -13.46% |
| 2022 | CN¥3.43 Billion | +72.29% |
| 2021 | CN¥1.99 Billion | +23.47% |
| 2020 | CN¥1.61 Billion | +8.28% |
| 2019 | CN¥1.49 Billion | -13.05% |
| 2018 | CN¥1.71 Billion | -0.16% |
| 2017 | CN¥1.72 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of SonoScape Medical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.28 Billion USD |
| MoneyControl | $1.28 Billion USD |
| MarketWatch | $1.28 Billion USD |
| marketcap.company | $1.28 Billion USD |
| Reuters | $1.28 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SonoScape Medical Corp
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, ligh… Read more